Device Trial Radar · NCT04349046
Exception Cementless Hip Stem
Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
332
Planned (sponsor's estimate)
Start
Jan 1, 2021
Primary completion
May 1, 2025
Study completion Dec 2026
Sponsor
- Lead sponsor
- Zimmer BiometPublic (ZBH)
- Sponsor type
- Industry
- First posted
- Apr 16, 2020
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 100 years
Summary
As written by the sponsor on the registry.
This study is a multicenter, retrospective and prospective, non-controlled, non-randomized post market clinical follow-up study. The objectives of this study are to confirm the long-term safety, performance and clinical benefits the Exception Cementless femoral stem (standard and varized) when used in primary total hip arthroplasty.
Conditions
- Osteoarthritis, Hip
- Rheumatoid Arthritis
- Inflammatory Arthritis
- Congenital Hip Dysplasia
- Avascular Necrosis of Hip
- Femoral Neck Fractures
Interventions
Total hip arthoplasty (THA)Device
Total hip arthroplasty (THA) is a common operative treatment where an arthritic, degenerative or fractured hip joint is replaced with a prosthetic device if conservative options are unable to relieve pain and debilitating symptoms. THA was traditionally performed on patients over 60 years old, but now includes young and active patients, as well as very old ones thanks to the continuous improvement in implant design. Major indications of THA include osteoarthritis, rheumatoid arthritis, avascular necrosis and hip fractures. The THA surgical procedure involves replacing the head of the femur and acetabulum or socket with an artificial prosthesis. This system is composed of a femoral stem that is inserted into the femoral canal, a ball that attaches to the femoral stem, and an acetabular component or shell that replaces the acetabulum.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Implant survival based on removal or intended removal of the device and determined using the Kaplan-Meier methodTime frame: 10 years post-surgery
Locations
6 sites in 2 countries. Site status is shown where the registry gives one.
Hôpital Princesse Paola
Aye, Belgium
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.